Thrombin: A neuronal cell modulator

Thrombosis Research

Volumn 99, Issue 5, 2000, Pages 417-427

  Turgeon, Victoria L ^a   Salman, Nadim ^a   Houenou, Lucien J ^b  

^a FURMAN UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Nervous system; Neuronal degeneration; Neuronal development; PAR; Thrombin

Indexed keywords

CELL RECEPTOR; MESSENGER RNA; PROTEINASE ACTIVATED RECEPTOR 1; PROTHROMBIN; THROMBIN; THROMBIN INHIBITOR; THROMBIN RECEPTOR;

ENZYME ACTIVATION; HUMAN; HUMAN CELL; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; SECOND MESSENGER; THROMBOCYTE;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NERVE TISSUE PROTEINS; NEURONS; NEUROTRANSMITTER AGENTS; THROMBIN;

EID: 0034283288     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00300-5     Document Type: Review

References (117)

1. Perraud F, Besnard F, Sensenbrenner M, Labourdette G. Thrombin is a potent mitogen for rat astroblasts but not for oligodendroblasts and neuroblasts in primary culture. Int J Dev Neurosci 1987;5:181-8.
2. Gurwitz D, Cunningham D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 1988;85:3440-4.
3. Gurwitz D, Cunningham D. Neurite out-growth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition. J Cell Physiol 1990;142:155-62.
4. Suidan HS, Stone SR, Hemmings BA, Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 1992;8:363-75.
5. Beecher KL, Andersen TT, Fenton JWII, Festoff BW. Thrombin receptor peptides induce changes in neonatal murine astrocytes in culture. J Neurosci Res 1994;37:108-15.
6. Turgeon VL, Lloyd ED, Wang S, Festoff BW, Houenou LJ. Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J Neurosci 1998;18:6882-91.
7. Turgeon VL, Milligan CE, Houenou LJ. Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J Neuropath Exper Neurol 1999;58:499-504.
8. Zurn AD, Nick H, Monard D. A glia-derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev Neurosci 1988;10:17-24.
9. Grabham PW, Grand RJ, Gallimore PH. Purification of a serum factor which reverses dibutyryl cAMP induced differentiation. Cell Signal. 1989;1:269-81.
10. Grand RJ, Grabham PW, Gallimore MJ, Gallimore PH. Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independent from blood coagulation. EMBO 1989;8:2209-15.
11. Davis-Salinas J, Saporito-Irwin SM, Donovan FM, Cunningham DD, Van Nostrand WE. Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor. J Biol Chem 1994;269:22623-7.
12. Snider RM, McKinney MJ Fenton JWII, Richelson E. Thrombin binding and stimulation of cGMP formation in neuroblastoma cells. Sem Thromb Hemost 1986;12:253-62.
13. Seiler SM, Michel IM, Fenton JWII. Involvement of the 'tethered-ligand' receptor in thrombin inhibition of platelet adenylate cyclase. Biochem Biophys Res Comm 1992;182:1296-1302.
14. Neveu I, Jehan F, Jandrot-Perrus M, Wion D, Brachet P. Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: a possible involvement of thrombin. J Neurochem 1993;60:858-67.
15. Loret C, Sensenbrenner M, Labourdette G. Differential phenotypic expression induced in cultured rat astroblasts by acidic fibroblast growth factor, epidermal growth factor and thrombin. J Biol Chem 1989;264:8319-27.
16. Cavanaugh KP, Gurwitz D, Cunningham DD, Bradshaw RA. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 1990;54:1735-43.
17. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 1991;6:575-81.
18. Soifer SJ, Peters KG, O'Keefe J, Coughlin SR. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Amer J Pathol 1994;144:60-9.
19. Means ED, Anderson DK. Thrombin interaction with central nervous system tissue and implication of these interactions. Annals NY Acad Sci 1986;485:314-22.
20. Weinstein JR, Gold SJ, Cunningham DD, Gall CM. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 1995;15:2906-19.
21. McKinney M, Snider RM, Richelson E. Thrombin binding to human brain and spinal cord. May Clin Proc 1983;58:829-31.
22. Jalink K, Moolenaar WH. Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J Cell Biol 1992;118:411-9.
23. Brewer G. Exogenous thrombin inhibits neuritogenesis in cultured neuroblastoma cells but not in rat hippocampal neurons. Brain Res 1995;683:258-63.
24. Brewer GJ. Thrombin causes cell spreading and redistribution of β-amyloid immunoreactivity in cultured hippocampal neurons. J Neurochem 1996;67:119-30.
25. Hung DT, Wong YH, Vu T-KH, Coughlin SR. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 1992;267:20831-4.
26. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J Neurosci 1995;15:5840-50.
27. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 1997;15:5316-26.
28. Yang Y, Haruhiko A, Fenton JWII, Brewer G. Thrombin receptor on rat primary hippocampal neurons: coupled calcium and cAMP responses. Brain Res 1997;761:11-8.
29. De la Houssaye BA, Mikule K, Nikolic D, Pfenninger KH. Thrombin-induced growth cone collapse: involvement of phospholipase A2 and eicosanoid generation. J Neurosci 1999;19:10843-55.
30. Deschepper CF, Bigorma V, Berens ME, Lapointe MC. Production of thrombin and antithrombin III by brain and astroglial cell cultures. Mol Brain Res 1991;11:355-8.
31. Davie EW, Fujikawa K, Kurachi K, Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol Res 1989;48:277-318.
32. Kaufman R, Patt S, Kraft R, Zieger M, Henklein P, Neupert G, Nowak G. PAR-1 type thrombin receptors are involved in thrombin-induced calcium signaling in human meningioma cells. J Neurooncol 1999;42:131-6.
33. Snider RM, McKinney MJ, Fenton JWII, Richelson E. Activation of cyclic nucleotide formation in murine neuroblastoma N1E-115 cells by modified human thrombin. J Biol Chem 1984;259:9031-78.
34. Niclou S, Suidan HS, Brwon-Luedi M, Monard D. Expression of the thrombin receptor mRNA in rat brain. Cell Mol Biol 1994;40:421-8.
35. Vu TH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mecha-nism of receptor activation. Cell 1991;64:1057-68.
36. Suttner J, Dyr JE, Doleckova L. Determination of the putative binding sites for thrombin receptor activating peptide through a hydropathic complementary approach. Thromb Haemost 2000;83:165-70.
37. Turgeon VL and Houenou J. The role of thrombin-like serine proteases in the development, plasticity and pathology of the nervous system. Brain Res Rev 1997;25:85-93.
38. Olejar T, Nouza K. Thrombin and trypsin receptors: the same mechanism of signaling on cellular surfaces. Bratisl Lek Listy 1999;100:75-9.
39. Cupit LD, Schmidt VA, Bahou WF. Proteolytically activated receptor-3. A member of an emerging gene family of protease receptors expressed on vascular endothelial cells and platelets. Trends Cardiovas Med 1999;9:42-8.
40. Brass LF. Regulation of phosphoinositide hydrolysis pathway in thrombin-stimulated platelets by pertussis toxin-sensitive guanine nucleotide-binding protein. J Biol Chem 1986;261:16833-47.
41. Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996;313:353-68.
42. Herang CL, Ives HE. Growth inhibition by protein kinase C late in mitogenesis. Nature 1987;329:849-50.
43. Garcia JGN, Aschner JL, Malik AB. Regulation of thrombin-induced endothelial barrier dysfunction and prostaglandin synthesis 1. New York: Plenum Press; 1992.
44. Jalink K, van Corven EJ, Hengeveld T, Morii N, Narumiya S, Moolenaar WH. Inhibition of lysophosphatidate - and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol 1994;126:801-10.
45. Chen Y. Activation of Src family kinase activity by the G-protein coupled thrombin receptor in growth responsive fibroblasts. J Biol Chem 1995;269:27327-77.
46. Ellis CA, Malik AB, Gilchrist A, Hamm H, Sandoval R, Voyno-Yasenetskaya T, Tiruppathi C. Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of G1-linked Ras/ mitogen-activated protein kinase pathway. J Biol Chem 1999;274:13718-27.
47. Oppenheim RW, Prevette D, Tytell M, Homma S. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. Dev Biol 1990;138:104-13.
48. Milligan CE, Oppenheim RW, Schwartz LM. Motoneurons deprived of trophic support in vitro require new gene expression to undergo programmed cell death. J Neurobiol 1994;25:1005-16.
49. Alnermi ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
50. Milligan CE, Prevette D, Yaginuma H, Homma S, Cardwell C, Fritz LC, Tomaselli KJ, Oppenheim RW, Schwarts L. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 1995;15:385-93.
51. Smirnova IV. Zhang SX, Citron BA, Arnold PM, Festoff BW. Thrombin is a death signal that activates intracellular death protease pathways in motor neurons. J Neurobiol 1998;36:64-80.
52. Stefanis L, Troy CM, Haiquing Q, Lloyd A. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J Neurochem 1997;69:1425-37.
53. Turgeon VL, Houenou LJ. Prevention of motoneuron degeneration induced by thrombin with different neurotrophic agents in highly enriched cultures. J Comp Neurol 1999;38:571-80.
54. Barinaga M. Forging a path to cell death. Science 1996;273:735-7.
55. Gebbink M, Kranenburg O, Poland M, van Horck, FPG, Houssa B, Moolenaar WH. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J Cell Biol 1997;137:1603-13.
56. Tapon N, Hall A. Rho, Rac, and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 1997;9:86-92.
57. Zipkin LD, Kindt RM, Kenyon CJ. Role of a new Rho family member in cell migration and axon guidance in C. elegans. Cell 1997;90:883-94.
58. Baker JB, Low DA, Simmer RL, Cunningham DD. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980;21:37-45.
59. Low DA, Baker JB, Koone WC, Cunningham DD. Released protease-nexin regulates cellular binding, internalization and degradation of serine proteases. Proc Natl Acad Sci USA 1981;78:2340-4.
60. Cunningham DD, Van Nostrand WE, Farrell DH, Campbell CH. Proteases in biological control and biotechnology. New York: Alan R. Liss, Inc; 1987.
61. Abraham CR, Slekow D, Potter H. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988;52:487-501.
62. Struss D, Storck J, Zimmerman RE. The inhibition of thrombin and chymotrypsin by heparin-cofactor III. Thromb Res 1992;68:45-56.
63. Oppenheim RW. The neurotrophic theory and naturally occurring motoneuron death. TINS 1989;12:252-5.
64. Oppenheim RW. Cell death during development of the nervous system. Ann Rev Neurosci 1991;14:453-501.
65. Dahm LM, Landmesser LT. The regulation of intramuscular nerve branching during normal development and following activity blockade. Dev Biol 1988;130:621-44.
66. Landmesser LT. The relationship of intramuscular nerve branching and synaptogenesis to motoneuron survival. J Neurobiol 1992;23:1131-9.
67. Tanaka H. Chronic application of curare does not increase the level of motoneuron survival-promoting activity in limb muscle extracts during the naturally occurring motoneuron cell death period. Dev Biol 1987;124:347-57.
68. Houenou LJ, McNanaman JL, Prevette D, Oppenheim RW. Regulation of putative muscle-derived neurotrophic factors by muscle activity and innervation: in vivo and in vitro studies. J Neurosci 1991;11:2829-37.
69. Oppenheim RW, Prevetter D, Haverkemp LJ, Houenou LJ, Yin QW, McNamaman J. Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo. J Neurobiol 1993;24:1065-79.
70. Monard D. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. TINS 1988;11:541-4.
71. Pittman RN. Neuron-target cell interaction may involve protease-inhibitor interactions. Soc Neurosci 1984;10:662 Abst.
72. Dennis MJ. Development of the neuromuscular junction: inductive interactions between cells. Ann Rev Neurosci 1981;4:43-68.
73. Festoff BW, Hantai D. Plasminogen activators and inhibitors, roles in muscle and neuromuscular regeneration. Prog Brain Res 1987;71:423-431.
74. Sperry RW. Chemoaffinity in the orderly growth of nerve fiber patterns and connections. Proc Natl Acad Sci, USA 1963;50:703-704.
75. Festoff BW, Rao JS, Maben C, Hantai D. Plasminogen activators and their inhibitors in the neuromuscular system I: Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines. J Cell Physiol 1990;144:262-271.
76. Ho GJ, Smirnova IV, Akaabourne M, Hantai D, Festoff BW. Serine proteases and their serpin inhibitors in Alzheimer's disease. Biomed Pharmacother 1994;48:296-304.
77. Gilad GM, Varon LE. Tranglutaminase activity in the rat brain: characterization, distribution, and changes with age. J Neurochem 1985;45:1522-1526.
78. Lee P, Spector JG, Derby A, Roufa DG. Effects of thrombin and protease nexin-1 on peripheral nerve regeneration. Ann Otol Rhinol Laryngol 1998;107:61-9.
79. Smirnova IV, Ma JV, Citron BA, Ratzlaff KT, Gregory EJ, Akaabourne M, Festoff BW. Neural thrombin and protease nexinl kinetics after murine periperal nerve injury. J Neurochem 1996;67:2188-99.
80. Trejo J, Chambord JC, Karin M, Brown JH. Biphasic increase in c-jun mRNA is required for induction of AP-1-mediator gene transcription: differentiation effects of muscarinic and thrombin receptor activation. Mol Cell Biol 1992;12:4742-50.
81. Enhrenreich H, Costa T, Clouse KA, Pluta RM, Ogino Y, Coligan JE, Burd PR. Thrombin is a regulator of astrocyte endothelin-1. Brain Res 1993;600:201-7.
82. Pike CJ, Vaughan PJ, Cunningham DD, Cotman CW. Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J Neurochem 1996;66:1374-82.
83. Berndt M, Phillips D. Platelet membrane proteins: composition and receptor functions. In: Gordon J, editor. Platelets in biology and pathology. Amsterdam: Elsevier; 1981. p. 43-7.
84. Bar-Shavit R, Kahn A, Fenton JWII, Wilner GD. Rector-mediated chemotactic response of a macrophage cell line (J774) to thrombin. Lab Invest 1983;49:702-7.
85. Glenn KC, Carney DH, Fenton JW, Cunningham DD. Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem 1980;225:6609-16.
86. Smith-Swintowsky VL, Zimmer S, Fenton JWII, Mattson MP. Opposing actions of thrombin and protease nexin-1 on amyloid β-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J Neurochem 1995;65:1415-8.
87. Choi BH, Suzuki M, Kim T, Wagner SL, Cunningham DD. Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Amer J Pathol 1990;137:741-7.
88. Garcia JGN, Siflinger-Birnboim A, Bizios R, Del Veech PJ, Fenton JWII, Malik AB. Thrombin-induced increases in albumin transport across cultured endothelial mono-layers. J Cell Physiol 1986;128:96-104.
89. Malik AB, Lo SK, Bizios R. Thrombin-induced alteration sin endothelial permeability. Ann NY Acad Sci 1986;485:293-309.
90. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993;10:167-170.
91. Kalarai RN. The blood brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovas Brain Metab Rev 1992;4:226-60.
92. Hoffman MC, Nilson C, Scotti A, Reinhard E, Monard D. The prolonged presence of glial-derived nexin, a serine protease inhibitor, in the hippocampus after transient global ischemia. Neurosci 1992;49:397-408.
93. Nitsch C, Scotti AL, Monard D, Heim C, Sontag KH. The glia-derived protease nexin-1 persists for over one year in rat brain area selectively lesioned by transient global ischemia. Eur J Neurosci 1993;5:292-7.
94. Suzuki M, Ogawa A, Sakurai Y, Nishino A, Venohara K, Mizoi K, Yoshimoto T. Thrombin activity in cerebrospinal fluid after subarachnoid hemorrhage. Stroke 1992;23:1181-2.
95. Vaughan DJ, Cunningham DD. Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J Biol Chem 1993;268:3720-7.
96. Hawkins RL, Seeds NW. Effects of proteases and their inhibitors in neurite outgrowth from neonatal mouse sensory ganglia in culture. Brain Res 1986;398:63-70.
97. Glenner GC, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890.
98. Haas C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL. Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-5.
99. Seubert P, Vigo-Pelfry C, Esh F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D. Isolation and quanitification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-7.
100. Busciglio J, Gabuzda DH, Matsudaira P, Yanker BA. Generation of β-amyloid in the secretory pathway in neuronal and non neuronal cells. Proc Natl Acad Sci, USA 1993;90:2092-6.
101. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487-98.
102. Igarashi K, Murai H, Asaka J. Proteolytic processing of amyloid beta protein precursor (APP) by thrombin. Biochem Biophys Res Commun 1992;185:1000-1004.
103. Choi BH, Kim RC, Vaughan PJ, Lau A, Van Nostrand WE, Cotman CW, Cunningham DD. Decreases in protease nexins in Alzheimer's disease brain. Neurobiol Aging 1995;16:557-62.
104. Wagner SL, Geddes JW, Cotman CW, Lau AL, Gurwitz D, Jackson PJ, Cunningham DD. Protease nexin-1, an antithrombin with neurite outhgrowth activity, is reduced in Alzheimer's disease. Proc Natl Acad Sci, USA 1989;86:8284-8.
105. Akiyama H, Ikeda K, Kondo H, McGeer PI. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 1992;146:152-154.
106. Mortimer JA, Vanduijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kikmen E, Kondo K, Rocca WA, Shalat SL, Soininen H, Hofman A. Head trauma as a risk for Alzheimer's disease - a collaborative re-analysis of case control studies. Int J Epidemiol 1991;20:S28-S35.
107. Aoyagi T, Wada T, Kojima F, Nagai M, Harada S, Takeuchi T, Isse K, Ogura M, Hamamoto M, Tanka K, Nagao T. Deficiency of fibronylytic enzyme activities in the serum of patients with Alzheimer's-type dementia. Exper 1992;48:656-9.
108. Siman R, Noszek JC, Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 1989;9:1579-90.
109. Yanagihara Y, Brengman JM, Mushynski WE. Differential vulnerability of microtubule components in cerebral ischemia. Acta Neuropath 1990;80:499-505.
110. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydell RE. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992;12:376-89.
111. Brass LF, Manning DR, Williams AG, Woolkalis MJ, Poncz M. Receptor and G protein mediated responses to thrombin in HEL cells. J Biol Chem 1991;266:958-65.
112. 2+ mobilization. FEBS Lett 1991;288:123-8.
113. Mattson MP, Taylor-Hunter A, Kater SB. Neurite outgrowth in individual neurons of a neuronal population is differentially regulated by calcium and cyclic AMP. J Neurosci 1988;8:1704-11.
114. Mattson MP, Murrain M, Guthrie, Kater SB. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci 1989;9:3728-40.
115. Mattson MP. Secreted forms of β-amyloid precursor protein modulate dendritic outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J Neurobiol 1993;25:439-50.
116. Gilad GM, Varon LE, Gilad VH. Calcium-dependent transglutaminase of rat sympathetic ganglion in development and after nerve injury. J Neurochem 1985;44:1385-1390.
117. Vaughan PJ, Pike CJ, Cotman CW, Cunningham DD. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 1995;157:5389-5401.